RNAimmune competitorsClear all
CureVac's top competitors include RNACure and Ufovax.
 CureVac CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology. |  RNACure RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis. |  Ufovax Ufovax is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. | |
Founding Date | Founding Date 2000 | Founding Date 2019 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE Tübingen, DE Boston, US | Locations Shanghai, CN HQ | Locations Wilmington, US HQ |
Employees | Employees 4004% increase | Employees 5 | Employees N/A |
Operating ⚠ | |||
Patents Issued | Patents Issued 233 (May, 2020) | Patents Issued N/A | Patents Issued 1 (May, 2020) |
For sources of this data, please see the company profile
View company profiles
RNACure
HQ
Shanghai, CN
Employees
5
RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.
View companyUfovax
HQ
Wilmington, US
Ufovax is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology.
View company